Factors associated with the use of various medications amongst patients with severe coronary artery disease
- 1 February 1999
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 245 (2) , 143-153
- https://doi.org/10.1046/j.1365-2796.1999.0425f.x
Abstract
Aim. To describe variations by age, sex, symptom severity and hospital region in the use of various medications amongst patients with stable angina pectoris who are candidates for coronary revascularization.Patients. Patients (n = 2030) with chronic stable angina pectoris participating in a national survey evaluating the appropriateness of the use of percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG).Methods. As part of a national study of the appropriateness of coronary revascularization, data were prospectively collected on patients referred for consideration of coronary revascularization to seven of the eight public Swedish heart centres that performed approximately 92% of all bypass operations in Sweden in 1994.Results. Amongst all patients 76% were treated with beta blockers, 41% with calcium antagonists and 71% with long‐acting nitrates and 70% were treated with at least two of these three drugs. Eighty‐two per cent of the patients used aspirin and 14% lipid‐lowering drugs. According to logistic regression analysis, with medication as the dependent variable and independent variables of age, sex, angina functional class, findings at exercise test, history of various diseases and region in Sweden where the investigation took place, the most consistent factor explaining the use of various medications was found to be geographical region. A previous history of acute myocardial infarction (AMI) was also associated with the use of all drugs and age was associated with all with the exception of beta blockers. Sex was not an independent factor explaining the use of any of the drugs.Conclusion. In a national survey including patients with stable angina pectoris who are potential candidates for coronary revascularization, the most important predictor for the use of various medications was the geographical region in which the investigation took place.Keywords
This publication has 31 references indexed in Scilit:
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Reducing the risk of coronary events: Evidence from the Scandinavian Simvastatin survival study (4S)The American Journal of Cardiology, 1995
- Regional Variation across the United States in the Management of Acute Myocardial InfarctionNew England Journal of Medicine, 1995
- Short and long-acting oral nitrates for stable angina pectorisCardiovascular Drugs and Therapy, 1994
- The appropriateness of performing coronary angiography and coronary artery revascularization in a Swedish populationPublished by American Medical Association (AMA) ,1994
- Gender differences in the treatment of patients with acute myocardial infarction. A multihospital, community-based perspectiveArchives of internal medicine (1960), 1993
- Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectorisThe Lancet, 1992
- Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable anginaThe Lancet, 1991
- Underutilization of thrombolytic therapy in eligible women with acute myocardial infarctionThe American Journal of Cardiology, 1991
- Combined Beta-Adrenergic and Calcium-Entry Blockade in Angina PectorisNew England Journal of Medicine, 1989